Targeted Delivery
Liposomal Technology
PlexoZome® is a scientifically proven complex liposomal technology. Our genuine liposomes are verified through TEM and Cryo-TEM imaging, Zeta potential and DLS testing. PlexoZome® formulations are made on site in our licensed facility, as such they are fully customisable stable liposomal ingredients.
PlexoZome® advantages
targeted delivery
scientifically validated genuine liposomes through TEM and Cryo-TEM imaging
fully customisable particle size, with DLS testing
improved stability, verified with Zeta Potential testing
supplied ready to use
Australian developed and made
Published Studies
PlexoZome® Curcumin modulates the synergistic role of EpCAM and estrogen receptor alpha.
This study delves into the in vitro potential of liposomal therapeutics utilising PlexoZome® Curcumin in targeting EpCAM/TROP1 and Estrogen Receptor Alpha (ERα) signalling pathways for LC management.
The effect of topical Palmitoylethanolamide (PlexoZome® Levagen) on Relief of post exercise joint knee pain.
Human studies have shown the effectiveness of PEA for joint pain. This study aimed to assess the effectiveness of a topical PEA (PlexoZome Levagen) spray on relieving knee joint pain post-exercise.
PlexoZome® is a trademark owned exclusively by Pharmako Biotechnologies Pty. Ltd., registered in Australia and other countries.